←Back to Expert Scholars
Translational Medicine / 转化医学Nivolumab Urologic Cancers
Padmanee Sharma
MD, PhD
🏢MD Anderson Cancer Center🌐USA
Professor, Genitourinary Medical Oncology and Immunology
115
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Padmanee Sharma led pivotal nivolumab trials in urothelial and renal cell carcinoma including CheckMate-275 and has advanced fundamental understanding of checkpoint inhibitor immunobiology. She directs translational immunology programs at MD Anderson.
Share:
🧪Research Fields 研究领域
bladder cancer immunotherapy
CheckMate-275
nivolumab urothelial
immune biology
CTLA4 PD1 combinations
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Padmanee Sharma 的研究动态
Follow Padmanee Sharma's research updates
留下邮箱，当我们发布与 Padmanee Sharma（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment